Esperion Therapeutics (ESPR) FY Conference June 09, 2025 10:40 AM ET Speaker0 Good morning, everyone. We'll continue with the next session, is Esperion Therapeutics. I'm Paul Choi, and I cover the biotech sector here at the firm. It's our pleasure to have Sheldon here with us once again this year to talk about Esperion and its commercial prospects, as well as the recent pipeline updates that they talked about at their analyst event. And so maybe just to kick it off, Sheldon, for those who may be unfamiliar ...